Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at  [email protected]  or 646-581-9980, ext. 7980.

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Phreesia, Inc. (NYSE: PHR) resulting from allegations that Phreesia may have issued materially misleading business information to the investing public. So What: If you purchased Phreesia securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The R.

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.